15 is International Angelman Syndrome Day, and the Synk family aims ... Trump's threat to annex Canada in meeting with King Charles Fast food chain says they’ve ‘RFK’d’ their fries ...

Last year, Zilganersen was granted fast track designation by the FDA ... our wholly-owned investigational medicine for Angelman syndrome, which we believe has transformational potential for ...

On February 7, Carlo Rizzuto, Versant Ventures managing director, appeared on CNBC’s ‘Fast Money’ to discuss ... including ION582 for Angelman syndrome, which is on track to start Phase ...

The investigational gene therapy enjoys the Regenerative Medicine Advanced Therapy, Fast Track ... antisense oligonucleotide, for Angelman syndrome (AS). The company is also on track to initiate ...

NNZ-2591 shows potential in treating neurodevelopmental condition with no approved therapies. Neuren Pharmaceuticals (ASX: NEU) has announced that the US Food and Drug Administration (FDA) has granted ...

The news: Neuren Pharmaceuticals was among the best-performing ASX 200 stocks in morning trade after securing a rare pediatric disease designation from the US Food and Drug Administration (FDA) for a ...

"Angelman Syndrome is a neurogenetic disorder," said Weston's mother Felicia Warner. "It affects a lot of different things. It affects their balance, a very high percentage has seizures ...